Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinri Pharmaceutical (China) Co., Ltd. is a prominent healthcare and pharmaceutical company headquartered in Xiamen, China, and serves as a core subsidiary of the Jinri Group. The company specializes in the research, development, and large-scale manufacturing of Traditional Chinese Medicine (TCM), health supplements, and pharmaceutical preparations. Its extensive product portfolio is anchored by high-quality American ginseng and cordyceps extracts, alongside a wide range of vitamins and minerals. Jinri operates modern production facilities that comply with national GMP standards for multiple dosage forms, including liquids, capsules, and tablets. Notably, the company holds a direct selling license in China, enabling a vast distribution network for its wellness and personal care products. Through its commitment to integrating traditional wisdom with modern science, Jinri has established itself as a household name in the Chinese health industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 金日制药.